Previous studies have clarified that miR‐101‐3p regulates various pivotal oncogenes and that downregulation of this miRNA affects cancer cell proliferation, metastasis, drug resistance, and angiogenesis via targeting of several oncogenic targets, e.g. EZH2, STMN1, VHL, SOX2, and DNMT3A (Wang et al., 2018). The gene discussed is EZH2; the disease is cancer.